Latest filing published 22 Feb 2016 for Valeant Pharmaceuticals International, Inc., €185k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Howard Bradley Schiller: trading record in brief
Howard Bradley Schiller discloses dealings in 2 companies, chiefly Valeant Pharmaceuticals International, Inc. and Bausch Health Companies Inc. In total, 31 filings cover trades dated from 1 December 2011 to 18 February 2016.
The open-market record is one-sided, with 8 purchases worth €3.8M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 18 share grants and 5 option exercises.
A typical purchase (the median) is worth €377k.
On 22 February 2016 came the latest disclosure, a share grant for €185k in Valeant Pharmaceuticals International, Inc. The last purchase on record was published on 8 November 2012, which is 5,114 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Howard Bradley Schiller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,245 shares@ US$91.454.2% of flowCommon Stock, no par valueSEC:0000885590-16-000087:0
- 51,846 shares@ US$91.4595.8% of flowCommon Stock, no par valueSEC:0000885590-16-000087:1
- 1,506 sharesCommon Stock, no par valueSEC:0000885590-16-000084:0
- 22,500 sharesCommon Stock, no par valueSEC:0000885590-15-000029:0
- 11,779 shares0Common Stock, no par valueSEC:0000885590-15-000029:1
- 4,859 shares0Common Stock, no par valueSEC:0000885590-15-000029:2
- 11,607 shares0Common Stock, no par valueSEC:0000885590-15-000009:0
- 45,000 shares0Common Stock, no par valueSEC:0000885590-15-000005:0
- 23,600 shares0Common Stock, no par valueSEC:0000885590-15-000005:1
- 22,500 shares0Common Stock, no par valueSEC:0000885590-14-000069:0
- 11,786 shares0Common Stock, no par valueSEC:0000885590-14-000069:1
- 4,849 shares@ US$122.05Common Stock, no par valueSEC:0000885590-14-000035:0
- 90,000 shares0Common Stock, no par valueSEC:0000885590-14-000019:0
- 44,855 shares0Common Stock, no par valueSEC:0000885590-14-000019:1
- 8,284 shares0Common Stock, no par valueSEC:0000885590-14-000012:0
- 3,000 shares0Common Stock, no par valueSEC:0000885590-14-000012:1
- 90,000 shares0Common Stock, no par valuesSEC:0000885590-13-000073:0
- 45,230 shares0Common Stock, no par valuesSEC:0000885590-13-000073:1
- 4,805 shares0Common Stock, no par valueSEC:0000885590-13-000022:0
- 18,300 shares0Common Stock, no par valueSEC:0000885590-13-000007:0
- 7,177 shares0Common Stock, no par valueSEC:0000885590-13-000007:1
- 18,300 shares@ US$54.10Common Stock, no par valueSEC:0000885590-12-000072:0Canonical exit: 4 Feb 2013 (T+90)
- 27,800 shares0Common Stock, no par valueSEC:0000885590-12-000030:0
- 9,200 shares@ US$53.53Common Stock, no par valueSEC:0000885590-12-000011:0Canonical exit: 4 Jun 2012 (T+90)
- 9,300 shares@ US$53.47Common Stock, no par valueSEC:0000885590-12-000010:0Canonical exit: 30 May 2012 (T+90)
25 of 31 declarations
